Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study

被引：0

作者：

Probert, C. ^{[1
]}

Gaya, D. R. ^{[2
]}

Hamlin, P. J. ^{[3
]}

Irving, P. ^{[4
,5
]}

Sebastian, S. ^{[6
]}

Gillespie, G. ^{[7
]}

Tate, H. ^{[7
]}

Wheeler, C. ^{[7
]}

机构：

[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England

[2] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland

[3] Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England

[4] Guys Hosp, London SE1 9RT, England

[5] St Thomas Hosp, London, England

[6] Hull & East Yorkshire NHS Trust, Kingston Upon Hull, N Humberside, England

[7] MSD UK, Hoddesdon, England

来源：

JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP049

引用

页码：S57 / S58

页数：2

共 50 条

[1] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS
Probert, C.
Gaya, D.
Hamlin, P. J.
Irving, P.
Sebastian, S.
Gillespie, G.
Tate, H.
Wheeler, C.
GUT, 2017, 66 : A8 - A8
[2] Patient-reported quality of life during golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
Irving, P.
Probert, C.
Gaya, D. R.
Hamlin, P. J.
Sebastian, S.
Gillespie, G.
Tate, H.
Wheeler, C.
JOURNAL OF CROHNS & COLITIS, 2016, 10 : S250 - S251
[3] PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY
Irving, P.
Probert, C.
Gaya, D.
Hamlin, P. J.
Sebastian, S.
Gillespie, G.
Tate, H.
Wheeler, C.
GUT, 2016, 65 : A87 - A87
[4] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GOCOLITIS STUDY
Probert, C.
Gaya, D.
Hamlin, P. J.
Irving, P.
Sebastian, S.
Gillespie, G.
Tate, H.
Wheeler, C.
GUT, 2016, 65 : A2 - A3
[5] GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS: PATIENT-REPORTED OUTCOMES OF PARTIAL MAYO SCORE RESULTS FROM THE GO-COLITIS STUDY
Sebastian, S.
Probert, C.
Gaya, D.
Hamlin, P. J.
Irving, P.
Gillespie, G.
Tate, H.
Wheeler, C.
GUT, 2017, 66 : A122 - A123
[6] Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
Probert, Christopher S. J.
Sebastian, Shaji
Gaya, Daniel R.
Hamlin, P. John
Gillespie, Gillian
Rose, Anita
Tate, Helen
Wheeler, Colin
Irving, Peter M.
Probert, C.
Gaya, D.
Sebastian, S.
Hart, A.
Irving, P.
Ahmad, T.
Pollok, R.
Orchard, T.
Arasaradnam, R.
Iqbal, T.
Johnson, M.
Kaser, A.
Allen, P.
Gordon, J.
Preston, C.
Shenderey, R.
Hoque, S.
Bloom, S.
Ansari, A.
Mowat, C.
Hamlin, J.
Arnott, I
Shaw, I
Steed, H.
Butterworth, J.
Robinson, A.
Mawdsley, J.
Creed, T.
Cummings, F.
BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
[7] PATIENT-REPORTED QUALITY OF LIFE DURING GOLIMUMABINDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS STUDY
Irving, P.
Sebastian, S.
Probert, C.
Gaya, D.
Hamlin, P. J.
Gillespie, G.
Tate, H.
Wheeler, C.
GUT, 2017, 66 : A8 - A8
[8] Pharmacokinetics of golimumab in patients with moderate-to-severe ulcerative colitis
Berends, S.
Strik, A.
van Egmond, P.
Brandse, H.
Mathot, R.
D'Haens, G.
Lowenberg, M.
JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S424
[9] Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
Midha, Vandana
Mahajan, Ramit
Mehta, Varun
Narang, Vikram
Singh, Arshdeep
Kaur, Kirandeep
Sood, Ajit
INTESTINAL RESEARCH, 2018, 16 (01) : 83 - 89
[10] Golimumab for moderate to severe ulcerative colitis
Strik, Anne S.
Berends, Sophie E.
Mathot, Ron A.
D'Haens, Geert R.
Lowenberg, Mark
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (05) : 401 - 406

← 1 2 3 4 5 →